Sanofi and GSK say they're near a vac­cine deal with EU hours af­ter fi­nal­iz­ing Warp Speed con­tract

2 days ago
Deals
Coronavirus

Trump’s ‘rad­i­cal’, ‘hor­ri­ble’ ex­ec­u­tive or­ders on drug pric­ing earn a C-suite back­lash this week — with one threat to do more over­seas

2 days ago
People
Bioregnum

Brigham and Wom­en's pres­i­dent Eliz­a­beth Nabel fol­lows Mon­cef Slaoui off Mod­er­na's board

3 days ago
People
Coronavirus

Sanofi and GSK grab largest Warp Speed deal yet, se­cur­ing $2.1B for a vac­cine that might come next year

3 days ago
Coronavirus

No­var­tis turns to Sang­amo with a $795M-plus deal aimed at us­ing zinc fin­ger tech for the neu­ro pipeline

3 days ago
Deals

UP­DAT­ED: The lead drug in Alex­ion’s $930M buy­out deal last fall just flopped — adding in­jury to an­a­lysts’ M&A in­sults

3 days ago
Deals
R&D

Adding $445M, Tony Coles and his big Pfiz­er neu­ro spin­out hitch a ride to Wall Street on Per­cep­tive’s SPAC

4 days ago
Venture

UP­DAT­ED: Genen­tech slash­es near­ly 500 jobs in strate­gic shift to 'lo­cal health­care ecosys­tems.' Clin­i­cal spe­cial­ists make up the biggest group

4 days ago
R&D
Pharma

Mod­er­na, Pfiz­er be­gin to give glimpse of Covid-19 vac­cine pric­ing — and prof­its

4 days ago
Pharma
Coronavirus

Roche/Genen­tech dou­bles down on tau, fronting $120M cash to al­ly on a 2-pronged strat­e­gy to fight Alzheimer’s

4 days ago
Deals

Sanofi prunes its pipeline, tak­ing the ax to a line­up of drug, vac­cine pro­grams

5 days ago
R&D

Covid-19 roundup: Mod­er­na re­moved signs around its man­u­fac­tur­ing plant — is it a tar­get for hack­ers?

5 days ago
Coronavirus

Roche de­clares a PhI­II fail­ure for Covid-19 as the IL-6 re­pur­pos­ing the­o­ry bites the dust

5 days ago
R&D
Coronavirus

Am­gen dumps ear­ly-stage CD38xCD3 bis­pe­cif­ic as 3 pro­grams are side­lined by tri­al set­backs

5 days ago
R&D

Dis­tanced from a pric­ing con­tro­ver­sy, Jeff Aronin steers one of his biotechs to Nas­daq — with a fa­mil­iar reg­u­la­to­ry strat­e­gy tied to a big bet

6 days ago
IPOs

Pfiz­er/BioN­Tech makes sur­prise choice in fi­nal dash to Oc­to­ber fin­ish line for Covid-19 vac­cine

6 days ago
Coronavirus

Covid-19 roundup: Pe­ter Kolchin­sky’s RA Cap­i­tal spear­heads 'Covid Apol­lo,' a VC search for the best test; Up­start grabs €23M for nanobod­ies

6 days ago
Coronavirus

Mod­er­na be­gins first US piv­otal Covid-19 vac­cine study, lands $472M more from BAR­DA

6 days ago
Coronavirus

TCR² re­leas­es ear­ly da­ta from some PhI pa­tients, spark­ing op­ti­mism from an­a­lysts

6 days ago
R&D

Covid-19 roundup: As­traZeneca builds $261M deal with US CD­MO play­er for bulk Covid-19 vac­cine sup­ply; Cor­po­rate in­sid­ers reel­ing in over $1B+

Last week
Coronavirus

As­traZeneca mines an­oth­er $6B ADC from Dai­ichi Sankyo, with block­buster am­bi­tions to ‘re­de­fine treat­ment stan­dards’

Last week
Deals

Bil­lion­aire Di­et­mar Hopp steers his se­cre­tive Covid-19 biotech play­er to Nas­daq fol­low­ing ma­jor pact with GSK

Last week
IPOs

Gilead’s Kite snares a land­mark FDA OK on a $373,000 CAR-T ther­a­py — which comes with brag­ging rights to the first true fran­chise op

Last week
Cell/Gene Tx
Regulatory

An­oth­er four biotechs make Wall Street de­but, rais­ing $772M+ as IPO tidal wave crests

Last week
IPOs
1234 Next page Last page